Clinical trial for new anti-obesity drug ready to launch at University of Alberta
IMAGE: Dr. Andrea Haqq (left) is leading the Canadian component of an international clinical trail to test an anti-obesity drug for patients with rare genetic disorders linked to obesity. view more Credit: University of Alberta The Alberta Diabetes Institute (ADI) will be at the centre of a new clinical trial for an anti-obesity drug targeting people…
Details